Terms: = Uterine cancer AND MAP2K1, MAPKK1, 5604, ENSG00000169032, Q02750, MEK1, MKK1, PRKMK1
37 results:
1. AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway.
Gan Q; Huang X; Zhao W; Liu H; Xu Y; Zhang X; Cheng J; Chen R
BMC Cancer; 2023 Apr; 23(1):364. PubMed ID: 37081411
[TBL] [Abstract] [Full Text] [Related]
2. An in vitro carcinogenesis model for cervical cancer harboring episomal form of HPV16.
Wongjampa W; Nakahara T; Tanaka K; Yugawa T; Ekalaksananan T; Kleebkaow P; Goshima N; Kiyono T; Pientong C
PLoS One; 2023; 18(2):e0281069. PubMed ID: 36763589
[TBL] [Abstract] [Full Text] [Related]
3. SEC61G Promotes Cervical cancer Proliferation by Activating MAPK Signaling Pathway.
Fan Y; Wang Y; Liu F; Wang H; Li Q
Dis Markers; 2022; 2022():7016079. PubMed ID: 36092956
[TBL] [Abstract] [Full Text] [Related]
4. Cobimetinib Sensitizes Cervical cancer to Paclitaxel via Suppressing Paclitaxel-Induced ERK Activation.
Liu Y; Zhao R; Qin X; Mao X; Li Q; Fang S
Pharmacology; 2022; 107(7-8):398-405. PubMed ID: 35526525
[TBL] [Abstract] [Full Text] [Related]
5. Epidermal growth factor receptor regulates fibrinolytic pathway elements in cervical cancer: functional and prognostic implications.
Gomes FG; Almeida VH; Martins-Cardoso K; Martins-Dinis MMDC; Rondon AMR; Melo AC; Tilli TM; Monteiro RQ
Braz J Med Biol Res; 2021; 54(6):e10754. PubMed ID: 33886813
[TBL] [Abstract] [Full Text] [Related]
6. "Metalloestrogenic" effects of cadmium downstream of G protein-coupled estrogen receptor and mitogen-activated protein kinase pathways in human uterine fibroid cells.
Yu L; Liu J; Yan Y; Burwell A; Castro L; Shi M; Dixon D
Arch Toxicol; 2021 Jun; 95(6):1995-2006. PubMed ID: 33818655
[TBL] [Abstract] [Full Text] [Related]
7. Molecular Profiles of Mixed Endometrial Carcinoma.
Matrai C; Motanagh S; Mirabelli S; Ma L; He B; Chapman-Davis E; Kurtis B; Elemento O; Mosquera JM; Ellenson LH
Am J Surg Pathol; 2020 Aug; 44(8):1104-1111. PubMed ID: 32604171
[TBL] [Abstract] [Full Text] [Related]
8. Inhibiting ubiquitin conjugating enzyme E2 N by microRNA-590-3p reduced cell growth of cervical carcinoma.
Song TT; Xu F; Wang W
Kaohsiung J Med Sci; 2020 Jul; 36(7):501-507. PubMed ID: 32196955
[TBL] [Abstract] [Full Text] [Related]
9. RCE‑4, a potential anti‑cervical cancer drug isolated from Reineckia carnea, induces autophagy via the dual blockade of PI3K and ERK pathways in cervical cancer CaSki cells.
Xiang W; Zhang RJ; Jin GL; Tian L; Cheng F; Wang JZ; Xing XF; Xi W; Tang SJ; Chen JF
Int J Mol Med; 2020 Jan; 45(1):245-254. PubMed ID: 31746346
[TBL] [Abstract] [Full Text] [Related]
10. Pharmacological, Mechanistic, and Pharmacokinetic Assessment of Novel Melatonin-Tamoxifen Drug Conjugates as Breast cancer Drugs.
Hasan M; Marzouk MA; Adhikari S; Wright TD; Miller BP; Matossian MD; Elliott S; Wright M; Alzoubi M; Collins-Burow BM; Burow ME; Holzgrabe U; Zlotos DP; Stratford RE; Witt-Enderby PA
Mol Pharmacol; 2019 Aug; 96(2):272-296. PubMed ID: 31221824
[TBL] [Abstract] [Full Text] [Related]
11. TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling.
Che Y; Li Y; Zheng F; Zou K; Li Z; Chen M; Hu S; Tian C; Yu W; Guo W; Luo M; Deng W; Zou L
Cancer Lett; 2019 Jun; 452():1-13. PubMed ID: 30905820
[TBL] [Abstract] [Full Text] [Related]
12. BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway.
Wang F; Chen Q; Huang G; Guo X; Li N; Li Y; Li B
BMC Cancer; 2018 Nov; 18(1):1128. PubMed ID: 30445932
[TBL] [Abstract] [Full Text] [Related]
13. A Novel Target of p53, TCF21, Can Respond to Hypoxia by MAPK Pathway Inactivation in uterine Corpus Endometrial Carcinoma.
Li Q; Lei Y; Du W
DNA Cell Biol; 2018 May; 37(5):473-480. PubMed ID: 29608330
[TBL] [Abstract] [Full Text] [Related]
14. Overexpression of the 14-3-3γ protein in uterine leiomyoma cells results in growth retardation and increased apoptosis.
Shen Q; Hu X; Zhou L; Zou S; Sun LZ; Zhu X
Cell Signal; 2018 May; 45():43-53. PubMed ID: 29382566
[TBL] [Abstract] [Full Text] [Related]
15. Praeruptorin A Inhibits Human Cervical cancer Cell Growth and Invasion by Suppressing MMP-2 Expression and ERK1/2 Signaling.
Wu MH; Lin CL; Chiou HL; Yang SF; Lin CY; Liu CJ; Hsieh YH
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267213
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-497 accelerates apoptosis while inhibiting proliferation, migration, and invasion through negative regulation of the MAPK/ERK signaling pathway via RAF-1.
Tao L; Zhang CY; Guo L; Li X; Han NN; Zhou Q; Liu ZL
J Cell Physiol; 2018 Oct; 233(10):6578-6588. PubMed ID: 29150931
[TBL] [Abstract] [Full Text] [Related]
17. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.
Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035
[TBL] [Abstract] [Full Text] [Related]
18. Antitumor activity of a combination of dual PI3K/mTOR inhibitor SAR245409 and selective mek1/2 inhibitor pimasertib in endometrial carcinomas.
Inaba K; Oda K; Ikeda Y; Sone K; Miyasaka A; Kashiyama T; Fukuda T; Uehara Y; Arimoto T; Kuramoto H; Wada-Hiraike O; Kawana K; Yano T; Osuga Y; Fujii T
Gynecol Oncol; 2015 Aug; 138(2):323-31. PubMed ID: 26033306
[TBL] [Abstract] [Full Text] [Related]
19. Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.
Schrauwen S; Depreeuw J; Coenegrachts L; Hermans E; Lambrechts D; Amant F
Gynecol Oncol; 2015 Jul; 138(1):165-73. PubMed ID: 25933683
[TBL] [Abstract] [Full Text] [Related]
20. [Estradiol activates MAPK signaling pathway by estrogen induced VEGF and bFGF in endometrial cancer cells].
Lu Y; Jiang S; Zhang J; Song H; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):925-31. PubMed ID: 25608994
[TBL] [Abstract] [Full Text] [Related]
[Next]
